Zebin Mao
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- Tendon Structure and Treatment
Papers in ⓘ
-
- Cancer, Hypoxia, and Metabolism 6
- Cancer-related molecular mechanisms research 5
- Aging 1
- Co-authors
- Changlong Yu (6 shared papers)Wenhui Zhao (5 shared papers)Wei Gu (4 shared papers)Bo Jin (7 shared papers)Bu‐Shan Xie (4 shared papers)K. Liu (5 shared papers)Hai‐Chao Han (3 shared papers)Xuelei Wei (4 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (4 papers)Journal of Biological Chemistry (3 papers)PLoS ONE (2 papers)Cell Death Discovery (1 paper)Neurochemical Research (1 paper)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Zebin Mao
47 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 337
- Orthopedics and Sports Medicine 130
- Molecular Biology 810
- Aging 17
- Geriatrics and Gerontology 30
Countries citing papers authored by Zebin Mao
This map shows the geographic impact of Zebin Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zebin Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zebin Mao more than expected).
Fields of papers citing papers by Zebin Mao
This network shows the impact of papers produced by Zebin Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zebin Mao. The network helps show where Zebin Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Zebin Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 116 | |
| 2 | 2016 | 90 | |
| 3 | 2009 | 77 | |
| 4 | 2006 | 64 | |
| 5 | 2015 | 62 | |
| 6 | 2014 | 54 | |
| 7 | 2015 | 54 | |
| 8 | 2013 | 53 | |
| 9 | 2011 | 52 | |
| 10 | 2005 | 50 | |
| 11 | 2020 | 42 | |
| 12 | 2018 | 37 | |
| 13 | 2020 | 36 | |
| 14 | 2015 | 36 | |
| 15 | 2010 | 36 | |
| 16 | 2012 | 36 | |
| 17 | 2012 | 32 | |
| 18 | Significance of pituitary tumor transforming gene 1 (PTTG1) in prostate cancer. | 2006 | 29 |
| 19 | 2006 | 28 | |
| 20 | 2019 | 27 |
About Zebin Mao
Zebin Mao is a scholar working on Cancer Research, Aging, Geriatrics and Gerontology, Molecular Biology and Complementary and Manual Therapy, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), Autophagy in Disease and Therapy (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA Interference and Gene Delivery (4 papers), RNA modifications and cancer (4 papers), Virus-based gene therapy research (3 papers), Telomeres, Telomerase, and Senescence (3 papers) and Knee injuries and reconstruction techniques (3 papers). The work is most often cited by research in Cancer Research (337 citations), Orthopedics and Sports Medicine (130 citations), Molecular Biology (810 citations), Aging (17 citations) and Geriatrics and Gerontology (30 citations). Zebin Mao has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Changlong Yu, Wenhui Zhao, Wei Gu, Bo Jin, Bu‐Shan Xie, K. Liu, Hai‐Chao Han, Xuelei Wei, Chenglin Wu and Yingming Zhao. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Biological Chemistry, PLoS ONE, Cell Death Discovery and Neurochemical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.